US House panel to debate biosimilars proposal
This article was originally published in Scrip
Executive Summary
US Democratic representative Anna Eshoo of California is expected to introduce a biosimilars legislative amendment that would give innovators up to 12.5 years of marketing exclusivity. The amendment, which would be attached to a healthcare reform bill currently under consideration by the House energy and commerce committee, could come as early as today when the panel is expected to resume deliberations.